Usana Health Sciences Inc (USNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Sales | 269,351 | 200,013 | 133,776 | 114,280 | 123,180 |
| Cost of Goods | 66,822 | 44,422 | 33,392 | 32,802 | 36,344 |
| Gross Profit | 202,529 | 155,591 | 100,384 | 81,478 | 86,836 |
| Operating Expenses | 158,505 | 124,894 | 87,983 | 78,080 | 81,725 |
| Operating Income | 44,846 | 31,119 | 12,793 | 4,200 | 5,455 |
| Interest Expense | 0 | 49 | 326 | 799 | 1,196 |
| Other Income | 233 | 241 | 105 | 107 | 519 |
| Pre-tax Income | 45,079 | 31,311 | 12,572 | 3,508 | 4,778 |
| Income Tax | 14,302 | 10,494 | 4,069 | 1,309 | 1,911 |
| Net Income Continuous | 30,777 | 20,817 | 8,503 | 2,199 | 2,867 |
| Net Income | $30,777 | $20,817 | $8,503 | $2,199 | $2,867 |
| EPS Basic Total Ops | 0.81 | 0.55 | 0.23 | 0.06 | 0.07 |
| EPS Basic Continuous Ops | 0.80 | 0.55 | 0.23 | 0.06 | 0.07 |
| EPS Diluted Total Ops | 0.76 | 0.49 | 0.21 | 0.06 | 0.07 |
| EPS Diluted Continuous Ops | 0.75 | 0.49 | 0.21 | 0.06 | 0.07 |
| EBITDA(a) | $49,686 | $34,996 | $16,930 | $8,316 | $9,641 |